Dr. Farhood Farjah Receives NIH Grant for Project “Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging”

Monday, February 7, 2022

Dr. Farhood Farjah, Endowed Chair in Lung Cancer Research, Associate Professor, Division of Cardiothoracic Surgery, received an NIH grant award for his project “Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging.”

“Our team’s goal is to reduce diagnostic and treatment errors, improve survival, and increase the value of care for lung cancer patients by improving our ability to select patients who benefit from a lymph node biopsy prior to starting treatment,” said Dr. Farjah. “This investigation determines the effectiveness of guideline recommended selection criteria for a pretreatment lymph node biopsy, and it tests whether a novel approach to selecting patients for lymph node biopsy is equivalent to guideline recommended strategy in terms of survival but superior in terms of lower biopsy-related severe adverse events and health expenditures. Findings from this study will lead to: 1) developing and testing implementation strategies designed to increase guideline-concordant lymph node evaluation, 2) alternative guideline recommendations for lymph node evaluation, and/or 3) justifying trials comparing outcomes between different lymph node evaluation strategies.”

Learn more about Dr. Farjah’s research and clinical interests and specialties.